Literature DB >> 6847836

Reversible and irreversible inhibition of thyroid peroxidase-catalyzed iodination by thioureylene drugs.

H Engler, A Taurog, C Luthy, M L Dorris.   

Abstract

The mechanism of reversible and irreversible inhibition of thyroid peroxidase (TPO)-catalyzed iodination by thioureylene drugs was investigated using a model incubation system. The major observations may be summarized as follows. 1) TPO is inactivated by 1-methyl-2-mercaptoimidazole and propylthiouracil even in the presence of a relatively high concentration of iodide. The extent of this inactivation depends on the ratio of iodide to drug. 2) Spectral changes observed on oxidation of the drugs with the peroxidase-iodide system were very similar to those observed when the drugs were oxidized nonenzymatically with I3-. These findings support the view that oxidized iodine is an intermediate in TPO-catalyzed oxidation of the drugs. 3) Under conditions where TPO is largely inactivated, inhibition of iodination is complete and irreversible. Drug metabolism, on the other hand, occurs to a limited extent. 4) Under conditions where TPO is only partially inactivated, inhibition of iodination is transient (reversible). In this case, drug metabolism is extensive, and higher oxidation products (sulfate and sulfinic acid) are observed. Inhibition of iodination occurs only during the interval required to reduce the drug concentration to a low level. Thereafter, iodination may occur at a rate close to that observed in the absence of drug. Based on these and other observations, a scheme is presented to explain the mechanism of reversible and irreversible inhibition of iodination. In essence, the type of inhibition depends on the relative rates and extent of TPO inactivation and drug oxidation. These rates, in turn, depend primarily on the iodide to drug concentration ratio. A high ratio favors extensive drug oxidation and reversible inhibition. A low ratio favors TPO inactivation and irreversible inhibition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847836     DOI: 10.1210/endo-112-1-86

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  The inhibitory effect of large doses of methimazole on iodine induced lymphocytic thyroiditis and serum anti-thyroglobulin antibody titers in BB/Wor rats.

Authors:  W Reinhardt; M C Appel; S Alex; Y N Yang; L E Braverman
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

2.  Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression.

Authors:  A P Weetman; M E Holt; A K Campbell; R Hall; A M McGregor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

3.  Adipose tissue-derived stem cells protect the primordial follicle pool from both direct follicle death and abnormal activation after ovarian tissue transplantation.

Authors:  Luciana Cacciottola; Guillaume E Courtoy; Thu Y T Nguyen; Camille Hossay; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  J Assist Reprod Genet       Date:  2020-11-12       Impact factor: 3.412

4.  Bioinorganic chemistry in thyroid gland: effect of antithyroid drugs on peroxidase-catalyzed oxidation and iodination reactions.

Authors:  Gouriprasanna Roy; G Mugesh
Journal:  Bioinorg Chem Appl       Date:  2006-11-12       Impact factor: 7.778

5.  Free Thyroxine, Anti-Thyroid Stimulating Hormone Receptor Antibody Titers, and Absence of Goiter Were Associated with Responsiveness to Methimazole in Patients with New Onset Graves' Disease.

Authors:  Hoon Sung Choi; Won Sang Yoo
Journal:  Endocrinol Metab (Seoul)       Date:  2017-06

6.  Agoitrous Graves' Hyperthyroidism with Markedly Elevated Thyroid Stimulating Immunoglobulin Titre displaying Rapid Response to Carbimazole with Discordant Thyroid Function.

Authors:  Yin Chian Kon; Brenda Su Ping Lim; Yingshan Lee; Swee Eng Aw; Yoko Kin Yoke Wong
Journal:  J ASEAN Fed Endocr Soc       Date:  2020-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.